Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.84
-0.05 (-0.85%)
Apr 21, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Stock Forecast
DCOY's stock price has decreased by -95.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Decoy Therapeutics stock has a target of 30, which predicts a 413.70% increase from the current stock price of 5.84.
Price Target: $30 (+413.70%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 23, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Decoy Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +413.70% | Jan 23, 2026 |
Financial Forecast
Revenue This Year
12.11M
Revenue Next Year
n/a
from 12.11M
EPS This Year
n/a
from -129.10
EPS Next Year
n/a
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 12.5M |
| Avg | 12.1M |
| Low | 11.6M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.